Translation Of RNA Nanomedicines From Design To Clinical

Different classes of RNA-based therapeutics include antisense oligonucleotides, aptamers, small interfering RNAs, microRNAs, and messenger RNA (mRNA). The widespread use of mRNA vaccines for COVID-19 marked 2020 as a breakout year for mRNA technology platforms.

mRNA therapeutics are applicable to cancer immunotherapies, infectious diseases, and other indications that require protein replacement therapy or antibodies.

Translation of RNA Nanomedicines from Design to Clinical presented by Dr. Heinrich Haas, Vice President RNA Formulation & Drug Delivery at BioNTech RNA Pharmaceuticals.